Marinus Pharma (MRNS) Second Phase 3 Is An Incremental Positive - Cantor

March 6, 2019 9:04 AM

Cantor Fitzgerald analyst, Elemer Piros, reiterated his Overweight rating on shares of Marinus Pharmaceuticals (NASDAQ: MRNS) after the company announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found